EVERSANA — Clindamycin Importer Profile
Pharmaceutical Importer · #16 buyer for Clindamycin · $6.3M import value · 183 shipments · UNITED STATES · DGFT Verified
EVERSANA is the #16 importer of Clindamycin from India with $6.3M in import value and 183 verified shipments. EVERSANA holds a 0.7% market share in Clindamycin imports based in UNITED STATES. The company sources from 4 verified suppliers across 98 formulations shipped to 1 country. Overall, EVERSANA imports 12 pharmaceutical products worth $27.6M across 9 therapeutic categories.
EVERSANA — Clindamycin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Clindamycin to EVERSANA?
Verified from 183 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MICRO LABS LIMITED | $3.5M | 86 | 55.2% |
| ZYDUS LIFESCIENCES LIMITED | $1.7M | 71 | 27.6% |
| MYLAN LABORATORIES LIMITED | $650.0K | 13 | 10.2% |
| CADILA HEALTHCARE LIMITED | $446.6K | 13 | 7.0% |
EVERSANA sources Clindamycin from 4 verified Indian suppliers based on 183 customs records. The primary supplier is MICRO LABS LIMITED accounting for 55.2% of imports.
How Does EVERSANA Compare to Nearest Clindamycin Importers?
Buyers ranked immediately above and below #16 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | AUROLOGISTICS LLC | UNITED STATES | $800.0K | 16 | $50.0K |
| 19 | WESSEX PHARMACEUTICALS LIMITED, | KENYA | $650.0K | 13 | $50.0K |
| 16 | EVERSANA ★ | UNITED STATES | $600.0K | 12 | $50.0K |
EVERSANA ranks #16 among 1,029 Clindamycin importers from India. Average shipment value of $50.0K compared to the market average of $30.8K. The closest competitors by value are AUROLOGISTICS LLC and WESSEX PHARMACEUTICALS LIMITED,.
Where Does EVERSANA Import Clindamycin To?
Destination countries from 183 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $6.3M | 183 | 100.0% |
EVERSANA imports Clindamycin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $6.3M.
What Clindamycin Formulations Does EVERSANA Import?
| Formulation | Value | Shipments |
|---|---|---|
| CLINDAMYCIN HYDROCHLORIDE CAPSULES, USP | $500.0K | 10 |
| PHARMA : CLINDAMYCIN PHOSPHATE TOPICAL S | $177.5K | 7 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXI | $150.0K | 3 |
| CLINDAMYCIN HYDROCHLORIDE CAPSULES, USP300MG ANDA NO 207402, NDC NO 42571-252-01. (INV,QTY.48216 ) (PACK 100S)NOS | $150.0K | 3 |
| CLINDAMYCIN HYDROCHLORIDE CAPSULES USP150MG ANDA NO 207402 NDC NO 42571-251-01 (PACK 100S) ( INV. QTY67500 )NOS | $150.0K | 3 |
| CLINDAMYCIN HYDROCHLORIDE CAPSULES, USP 300MG ANDA NO: 207402, NDC NO: 42571-252-01. INV.QTY 29184) (PACK 100 | $150.0K | 3 |
| CLINDAMYCIN HYDROCHLORIDE CAPSULES, USP 300MG ANDA NO: 207402, NDC NO: 42571-252-01. INV.QTY 38976) (PACK 100 | $150.0K | 3 |
| CLINDAMYCIN HYDROCHLORIDE CAPSULES USP300MG ANDA NO 207402 NDC NO 42571-252-01 (PACK 100S) ( INV. QTY19440 )NOS | $134.0K | 3 |
| CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION U | $133.6K | 4 |
| CLINDAMYCIN HYDROCHLORIDE CAPSULES USP300MG ANDA NO 207402 NDC NO 42571-252-01 (PACK 100S) ( INV. QTY 19176 ) TNOS | $132.9K | 3 |
EVERSANA imports 98 distinct Clindamycin formulations from India. The top formulation is CLINDAMYCIN HYDROCHLORIDE CAPSULES, USP with 10 shipments worth $500.0K.
Regulatory Requirements: Importing Clindamycin into United States
What EVERSANA and other importers must comply with to import Clindamycin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Clindamycin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Clindamycin from India and How Much Does EVERSANA Import?
India exported $31.6M worth of Clindamycin through 7,242 shipments from 527 suppliers to 144 countries, serving 1,029 buyers globally. EVERSANA imports $6.3M of this total, accounting for 0.7% of India's Clindamycin exports with 183 shipments from UNITED STATES. This is verified from 183 customs shipment records covering 98 distinct formulations.
What Is the Average Order Value for EVERSANA's Clindamycin Imports?
EVERSANA's average Clindamycin order value is $34.7K per consignment, based on 183 shipments totaling $6.3M. EVERSANA is based in UNITED STATES and ranks #16 among all Clindamycin importers from India by value. The company sources from 4 verified suppliers in India.
Who Supplies Clindamycin to EVERSANA?
EVERSANA sources Clindamycin from 4 verified Indian suppliers: MICRO LABS LIMITED ($3.5M, 55.2%), ZYDUS LIFESCIENCES LIMITED ($1.7M, 27.6%), MYLAN LABORATORIES LIMITED ($650.0K, 10.2%), CADILA HEALTHCARE LIMITED ($446.6K, 7.0%). This is based on 183 customs records.
How Does EVERSANA Compare to Other Clindamycin Importers?
EVERSANA ranks #16 among 1,029 Clindamycin importers from India with a 0.7% market share. The top 3 importers are CARDINAL HEALTH ($4.7M), AIM RX 3PL, LLC ($3.3M), EVERSANA LIFE SCIENCE SERVICES ($3.1M). EVERSANA processed 183 shipments from UNITED STATES.
What Other Antibiotics Products Does EVERSANA Import?
EVERSANA also imports these antibiotics products. Each links to the detailed product page.
About EVERSANA
EVERSANA imports 12 products worth $27.6M. Beyond Clindamycin, top products include Heparin, Enoxaparin, Syringe, Vancomycin, Sodium. View the complete EVERSANA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clindamycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clindamycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: EVERSANA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as EVERSANA's capped import value divided by total capped export value for Clindamycin across all Indian exporters.
- 5.Verified Records: This page is backed by 183 individual customs records matching EVERSANA importing Clindamycin, covering 98 formulations from 4 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 144+ countries, 1,029+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clindamycin Import Data for EVERSANA
Access order-level details, pricing data, supplier connections, and competitive analysis for EVERSANA's Clindamycin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
EVERSANA
Full Company Profile →
12 products · $27.6M total trade · 9 categories
EVERSANA × Clindamycin
Verified from customs records
Company Overview
Top Products by EVERSANA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for EVERSANA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clindamycin. For current order-level data, contact TransData Nexus.